HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yun-Hui Bi Selected Research

alisol B 23-acetate

7/2022Alisol B 23-acetate adjusts bile acid metabolisim via hepatic FXR-BSEP signaling activation to alleviate atherosclerosis.
11/2020Alisol B 23-acetate activates ABCG5/G8 in the jejunum via the LXRα/ACAT2 pathway to relieve atherosclerosis in ovariectomized ApoE-/- mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yun-Hui Bi Research Topics

Disease

2Atherosclerosis
07/2022 - 11/2020
1Arteriosclerosis
07/2022
1Atherosclerotic Plaque (Atheroma)
11/2020

Drug/Important Bio-Agent (IBA)

2alisol B 23-acetateIBA
07/2022 - 11/2020
1Bile Acids and Salts (Bile Acids)IBA
07/2022
1CholesterolIBA
07/2022
1Nonesterified Fatty Acids (NEFA)IBA
07/2022
1Phytosterols (Plant Sterols)IBA
11/2020
1Apolipoproteins E (ApoE)IBA
11/2020
1LipidsIBA
11/2020

Therapy/Procedure

1Therapeutics
07/2022